Clinical Trial Update: BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. [Phase 3]

View source ↗

Summary

This Clinical Trial Update describes the Phase 3 BONCURE study of monthly Bonviva (ibandronate) in women with postmenopausal osteoporosis on bisphosphonate ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post-Menopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2016-10-28